DA
BHVN icon

DCF Advisers’s Biohaven BHVN Stock Holding History

DCF Advisers’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2M Hold
134,500
– – 0.35% 48
2026
Q1 		$1.14M Buy
134,500
+87,500
+186% +$957K 0.3% 55
2025
Q4 		$531K Buy
47,000
+41,000
+683% +$508K 0.14% 81
2025
Q3 		$90.1K Buy
+6,000
New +$87.3K 0.03% 93

Other funds holding BHVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DCF Advisers's BHVN Position: Q2 2026 in Review

DCF Advisers increased its Biohaven (BHVN) stake by 5.3% in Q2 2026, buying an estimated $70K and bringing the position to 130,000 shares worth $1.93M. The position accounts for 0.34% of the portfolio, ranked #49.

DCF Advisers first reported a position in BHVN in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.57M in Q3 2025. 296 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • DCF Advisers held 130,000 shares of Biohaven worth $1.93M as of Q2 2026.
  • DCF Advisers bought 6,500 Biohaven shares in Q2 2026, an estimated $70K.
  • Biohaven made up 0.34% of DCF Advisers's portfolio in Q2 2026, its #49 holding.
  • DCF Advisers first reported a position in Biohaven in Q2 2024 and has held it in 9 quarters since.
  • DCF Advisers's Biohaven position peaked at $2.57M in Q3 2025.
  • 296 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on DCF Advisers's 13F filing for Q2 2026, filed 10 Aug 2026.